PAD Exercise Therapy
Definition
Exercise therapy for peripheral artery disease (PAD) encompasses supervised exercise therapy (SET) and structured community-based or home exercise programmes as first-line treatment for chronic symptomatic PAD (claudication). The 2024 ACC/AHA guidelines assign both SET and structured community/home exercise COR 1A — evidence that equals endovascular revascularisation in direct comparative trials.
Key Concepts
Supervised Exercise Therapy (SET)
- COR 1A for claudication: ≥30–45 min of active walking per session; ≥3 sessions per week; minimum 12-week programme. Medicare-covered in the United States since 2017. (sources/PVD-AHA-2024 — very high)
- CLEVER trial: SET = endovascular revascularisation (iliac stenting) for aortoiliac disease at 6 and 18 months; both were superior to medical care alone. This positions SET as therapeutically equivalent to revascularisation for functional improvement in appropriately selected claudicants.
- Mechanism: Repeated ischaemia-reperfusion cycles during supervised walking drive collateral vessel formation, skeletal muscle oxidative adaptation (mitochondrial density, fibre-type shift), and reduced oxygen demand — producing both vascular and metabolic benefit. (sources/PVD-AHA-2024)
- SET after revascularisation: COR 1A — provides additional functional benefit beyond revascularisation alone. Combined revascularisation + SET produces greater improvement than either modality alone (multiple RCTs and meta-analyses). (sources/PVD-AHA-2024)
Structured Community-Based and Home Exercise
- COR 1A: Structured community or home exercise incorporating defined protocols and behavioural change techniques is equally effective to SET as an alternative for patients unable to access supervised programmes. (sources/PVD-AHA-2024 — very high)
- Unstructured exercise ("go out and walk") is COR 2b — not demonstrated to improve outcomes in RCTs. Protocol structure and progression are the differentiating factors, not the location. (sources/PVD-AHA-2024)
Position in Treatment Algorithm
- Exercise is first-tier treatment for claudication (COR 1 B-R): Offered as an initial option alongside GDMT before revascularisation. Revascularisation for claudication is second-tier — only after inadequate response to GDMT including structured exercise. (sources/PVD-AHA-2024)
- Despite COR 1A status and Medicare coverage, SET referral rates remain ~2% in the United States — driven by access barriers, poor physician awareness, and logistical constraints. This implementation gap represents one of the most significant evidence-to-practice failures in cardiovascular medicine.
Health Disparities
- Black patients, women, rural patients, and lower socioeconomic groups have substantially lower access to SET and lower participation rates, compounding existing disparities in PAD outcomes. (sources/PVD-AHA-2024)
Contradictions / Open Questions
- SET referral rates vs guideline strength: The gap between COR 1A evidence and ~2% real-world referral is not attributable to safety concerns. Structural barriers, insurance complexity, and limited programme availability are the dominant reasons. (sources/PVD-AHA-2024)
- Exercise in CLTI: SET evidence is primarily in claudication; evidence for exercise therapy in chronic limb-threatening ischaemia (CLTI) is much weaker. Revascularisation takes priority in CLTI, and exercise alone is insufficient. (sources/PVD-AHA-2024)
Connections
- Related to concepts/PAD-Medical-Therapy
- Related to concepts/CLTI
- Related to concepts/Ankle-Brachial-Index
- Related to entities/Peripheral-Artery-Disease